sample

ABSTRACTIntroduction While there is mounting evidence of the independent prognostic value of patient-reported outcomes...

Posté par : Dr. Amélie ANOTA
Nom de la revue : BMJ Open

sample

AbstractBACKGROUND:The incidence of anal squamous cell carcinoma has been increasing markedly in the past few decades....

Posté par : Dr. Amélie ANOTA, Mme. Aurélia MEURISSE, Dr. Dewi VERNEREY
Nom de la revue : Lancet Oncol

sample

AbstractBACKGROUND:At time of diagnosis, less than 10% of patients with pancreatic adenocarcinomas (PDAC) are considered...

Posté par : Dr. Dewi VERNEREY
Nom de la revue : BMC Cancer

sample

ABSTRACTBackground: Cardiac toxicity with a decrease of the left ventricular ejection fraction (LVEF) is the main side...

Posté par : Dr. Sophie PAGET-BAILLY, Mme. Julie HENRIQUES
Nom de la revue : The Breast

sample

Letter to editor.LINK

Posté par : Dr. Edouard AUCLIN, Dr. Dewi VERNEREY
Nom de la revue : European Journal of Cancer

sample

BACKGROUND:Since 2004, a regimen of 6 months of treatment with oxaliplatin plus a fluoropyrimidine has been standard...

Posté par : Dr. Dewi VERNEREY
Nom de la revue : New England Journal of Medicine

sample

ABSTRACTPurpose Reduction of adjuvant treatment duration may decrease toxicities without loss of efficacy in stage III...

Posté par : Dr. Dewi VERNEREY, Dr. Sophie PAGET-BAILLY, Pr. Franck BONNETAIN
Nom de la revue : Journal of Clinical Oncology

sample

BACKGROUND:RAS mutations are currently sought for in tumor samples, which takes a median of almost 3 weeks in western...

Posté par : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN, Mme. Aurélia MEURISSE
Nom de la revue : Ann Oncol

sample

BACKGROUND:Expression of SRY [sex-determining region Y]-box11 (SOX11) is specific to mantle cell lymphoma (MCL) and...

Posté par : Dr. Dewi VERNEREY
Nom de la revue : Exp Hematol Oncol

sample

ABSTRACTBackground and objective: Health-related quality of life (HRQoL) has become one relevant and...

Posté par : Dr. Amélie ANOTA, Pr. Franck BONNETAIN
Nom de la revue : Computer Methods and Programs in Biomedicine

sample

With advances in breast cancer (BC) gene panel testing, risk counseling has become increasingly complex, potentially...

Posté par : Dr. Amélie ANOTA
Nom de la revue : International Journal of Environmental Research and Public Health

sample

PurposeThe aim of this study was to determine the prevalence of adherence to adjuvant hormonal therapy (AHT) and to...

Posté par : Mme. Julie HENRIQUES, Dr. Sophie PAGET-BAILLY, Dr. Amélie ANOTA
Nom de la revue : Breast Cancer Research and Treatment

sample

BackgroundPatients treated with chemotherapy for microsatellite unstable (MSI) and/or mismatch repair deficient (dMMR)...

Posté par : Dr. Dewi VERNEREY
Nom de la revue : Eur J Cancer

sample

AbstractBACKGROUND:Current prognostic systems for myelodysplastic syndromes (MDS) are based on clinical, pathologic, and...

Posté par : Dr. Amélie ANOTA, Pr. Franck BONNETAIN
Nom de la revue : Cancer

sample

AbstractBackgroundWe studied the relationship between intermediate criteria and overall survival (OS) in metastatic...

Posté par : Dr. Sophie PAGET-BAILLY, Pr. Franck BONNETAIN
Nom de la revue : Clinical Colorectal Cancer

sample

Advances in cancer care delivery require revision and further development of questionnaires assessing patients’...

Posté par : Dr. Amélie ANOTA, Pr. Franck BONNETAIN
Nom de la revue : European Journal of Cancer Care

sample

AbstractBackground: Genome-wide association studies (GWAS) have to date identified 94 genetic variants (single...

Posté par : Mme. Julie HENRIQUES, Dr. Sophie PAGET-BAILLY
Nom de la revue : Breast Cancer Research

sample

AbstractBackground The overexpression of human epidermal growth factor receptor-2 (HER2) in breast cancer is a poor...

Posté par : Pr. Franck BONNETAIN, Dr. Dewi VERNEREY
Nom de la revue : BMC Cancer

sample

We conducted a retrospective study to assess the follow-up of patients with localized breast cancer and the first...

Posté par : Mme. Aurélia MEURISSE,
Nom de la revue : Breast

sample

Abstract Aim: Adjuvant clinical trials in early human epidermal growth factor receptor 2 (HER2)-positive breast cancer...

Posté par : Mme. Julie HENRIQUES, Dr. Sophie PAGET-BAILLY
Nom de la revue : European Journal of Cancer

sample

Background: In advanced pancreatic ductal adenocarcinoma (aPDAC), there is no consensual strategy for...

Posté par : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN, Mme. Aurélia MEURISSE
Nom de la revue : JNCI J Natl Cancer Inst

sample

Since the MOSAIC study, oxaliplatin-based adjuvant chemotherapy has been the standard treatment of stage III colon...

Posté par : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN
Nom de la revue : Annals of Oncology

sample

AbstractTraditionally, the efficacy of cancer treatment in patients with advance or metastatic disease in clinical...

Posté par : Pr. Franck BONNETAIN
Nom de la revue : Annals of Oncology

sample

ABSTRACTIntroduction: Intermediate endpoints are often used as primary endpoints instead of overall survival (OS) in...

Posté par : , Pr. Franck BONNETAIN
Nom de la revue : Expert Review of Anticancer Therapy

sample

Background:To assess the efficacy of a patient educational program built according to guidelines that aims at reducing...

Posté par : Dr. Amélie ANOTA, Pr. Franck BONNETAIN
Nom de la revue : British Journal of Cancer

sample

Background Nab-paclitaxel plus gemcitabine has become a standard treatment regimen in patients with metastatic...

Posté par : Mme. Aurélia MEURISSE, Pr. Franck BONNETAIN
Nom de la revue : Lancet Gastroenterology Hepatology

sample

BackgroundEven if a large majority of out-of-hospital cardiac arrest (OHCA) survivors appear to have a good neurological...

Posté par : Pr. Franck BONNETAIN
Nom de la revue : Resuscitation

sample

RésuméLes données dans la littérature concernant les parcours de soins des patients atteints de cancer du pancréas...

Posté par : Pr. Franck BONNETAIN
Nom de la revue : Bulletin du Cancer

sample

La mesure de la qualité de vie relative à la santé des personnes traitées pour un cancer se développe. Ce nouvel...

Posté par : Mme. Ikram ES-SAAD, Dr. Sophie PAGET-BAILLY, Mme. Joëlle FRITZSCH, Dr. Guillaume MOUILLET, Pr. Franck BONNETAIN
Nom de la revue : La revue de l'infirmière

sample

Background: Medical progress and the lifestyle modification have prolonged life expectancy, despite the development of...

Posté par : Mme. Astrid POZET, Mme. Audrey FOUBERT, Mme. Morgane CHOTARD, Dr. Amélie ANOTA, Pr. Franck BONNETAIN
Nom de la revue : Trials

sample

AbstractBackground: Frailty is highly prevalent in elderly people. While significant progress has been made to...

Posté par : Dr. Dewi VERNEREY, Dr. Amélie ANOTA, Dr. Sophie PAGET-BAILLY, Mme. Audrey FOUBERT, Mme. Astrid POZET, Pr. Franck BONNETAIN
Nom de la revue : BMC Geriatrics

sample

AbstractBackground: Pancreatic adenocarcinoma (PDAC) incidence is increasing worldwide. Several studies have shown...

Posté par : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN
Nom de la revue : BMC Cancer

sample

Measures of health-related quality of life (HRQOL) and other patient-reported outcomes generate important data...

Posté par : Pr. Franck BONNETAIN
Nom de la revue : Lancet Oncology

sample

Docetaxel, cisplatin, and 5-fluorouracil (DCF) significantly improved overall survival in metastatic...

Posté par : , Dr. Sophie PAGET-BAILLY, Pr. Franck BONNETAIN
Nom de la revue : Cancer Medecine

sample

In first-line metastatic colorectal cancer (mCRC), baseline prognostic factors allowing death risk and treatment...

Posté par : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN
Nom de la revue : International Journal of Cancer

sample

AbstractTemozolomide (TEM) showed encouraging results in well-differentiated pancreatic neuroendocrine tumors (WDPNETs)....

Posté par : Dr. Dewi VERNEREY
Nom de la revue : Endocrine-Related Cancer

sample

AbstractThe diagnosis system for allograft loss lacks accurate individual risk stratification on the basis of...

Posté par : Dr. Dewi VERNEREY
Nom de la revue : J Am Soc Nephrol

sample

Background: The management of locally advanced pancreatic cancer (LAPC) patients remains controversial. Better...

Posté par : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN
Nom de la revue : British Journal of Cancer

sample

Our aim was to review the studies which assessed potential surrogate endpoints for overall survival (OS) in breast...

Posté par : Pr. Franck BONNETAIN,
Nom de la revue : Breast

sample

In the Intergroupe Francophone de Cancérologie Thoracique 0501 trial the carboplatinpaclitaxel chemotherapy increased...

Posté par : , Dr. Amélie ANOTA, Pr. Franck BONNETAIN
Nom de la revue : European Respiratory Journal

sample

Background: Even though the perioperative chemotherapy improves the overall survival (OS) compared to surgery alone in...

Posté par : Dr. Sophie PAGET-BAILLY, , Pr. Franck BONNETAIN
Nom de la revue : European Journal of Surgical Oncology

sample

PurposeWe previously showed that a sequential chemotherapy with dose-dense oxaliplatin (FOLFOX7)and irinotecan (FOLFIRI;...

Posté par : Pr. Franck BONNETAIN
Nom de la revue : PLOS ONE

sample

AbstractGlioblastoma is the most common malignant brain tumor in adults. Baselinehealth-relatedquality of life (HRQoL)...

Posté par : , Dr. Dewi VERNEREY, Dr. Amélie ANOTA, Pr. Franck BONNETAIN
Nom de la revue : Cancer Medicine

sample

OBJECTIVES: The objective of this study was to explore the association between health-related quality of life (HRQoL)...

Posté par : Dr. Amélie ANOTA, Pr. Franck BONNETAIN
Nom de la revue : BMJ Open

OBJECTIVES: We conducted a prospective study approved by the local ethics committee to determine the impact of a...

Posté par : Dr. Amélie ANOTA, Pr. Franck BONNETAIN
Nom de la revue : Annales pharmaceutiques françaises

sample

IMPORTANCE In locally advanced pancreatic cancer, the role of chemoradiotherapy is controversial and the efficacy of...

Posté par : Pr. Franck BONNETAIN
Nom de la revue : JAMA

sample

Health-related quality of life (HRQOL) in cancer research is critical to more comprehensively evaluate patients’...

Posté par : Pr. Franck BONNETAIN, , Dr. Amélie ANOTA
Nom de la revue : Journal of Clinical Oncology

sample

AbstractBackground: Health-related quality of life (HRQoL) is recognized as a component endpoint for cancer...

Posté par : , Dr. Amélie ANOTA, Pr. Franck BONNETAIN
Nom de la revue : BMC Cancer

sample

Background: Deficient mismatch repair (dMMR) colon cancer (CC) is reportedly resistant to 5-fluorouracil (5FU) adjuvant...

Posté par : Dr. Guillaume MOUILLET, Dr. Dewi VERNEREY, Pr. Franck BONNETAIN
Nom de la revue : JNCI Journal of the National Cancer Institure

sample

AbstractBACKGROUND:We investigated whether the health-related quality of life (HRQoL) score is a prognostic factor for...

Posté par : , Dr. Dewi VERNEREY, Pr. Franck BONNETAIN
Nom de la revue : EJC

sample

Purpose Eastern Cooperative Oncology Group Performance Status (ECOG-PS) is currently an important parameter in the...

Posté par : Pr. Franck BONNETAIN
Nom de la revue : Quality of Life Research

sample

AbstractPURPOSE:The MOSAIC (Multicenter International Study of Oxaliplatin/Fluorouracil/Leucovorin in the Adjuvant...

Posté par : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN
Nom de la revue : JCO

sample

AbstractBACKGROUND:The combination of an anti-VEGF or an anti-EGFR-targeted monoclonal antibody with chemotherapy has...

Posté par : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN
Nom de la revue : Lancet Oncol

sample

AbstractOBJECTIVES:To assess the long term outcomes of transplantation using expanded criteria donors (ECD; donors aged...

Posté par : Dr. Dewi VERNEREY
Nom de la revue : BMJ

sample

ABSTRACT Rationale:The role of circulating antibodies in addition to traditional cardiovascular risk factors in...

Posté par : Dr. Dewi VERNEREY
Nom de la revue : Test

sample

AbstractAIM:Microarray studies identified a subgroup of molecular apocrine tumors (estrogen receptor [ER]...

Posté par : Dr. Dewi VERNEREY
Nom de la revue : Future Oncol

sample

Abstract Background: Baseline prognostic biomarkers stratifying treatmentstrategies in first-line metastatic...

Posté par : Pr. Franck BONNETAIN, Dr. Dewi VERNEREY
Nom de la revue :

sample

AbstractOverall survival (OS) has been considered as the most relevant primary endpoint but trials using OS often...

Posté par : , , Dr. Amélie ANOTA, Dr. Dewi VERNEREY, Dr. Sophie PAGET-BAILLY, Pr. Franck BONNETAIN
Nom de la revue : Expert Review of Anticancer Therapy

sample

BACKGROUND:A randomized multicenter phase II trial was conducted to assess the sequential treatment strategy using...

Posté par : Dr. Amélie ANOTA, Dr. Guillaume MOUILLET, Dr. Sophie PAGET-BAILLY, Pr. Franck BONNETAIN
Nom de la revue : PlosOne

sample

AbstractBACKGROUND:The incidence of anal squamous cell carcinoma has been increasing markedly in the past few decades....

Posté par : Dr. Amélie ANOTA, Mme. Aurélia MEURISSE, Dr. Dewi VERNEREY
Nom de la revue : Lancet Oncol

2015-2018 © Copyright - UMQVC.org

Website by Pearlweb